The opioid addiction issue is headed for the next stop on what is now a well-worn path: from public health crisis, to subject for award-winning and heart-tugging journalism, to payday for trial lawyers.
The lawyers are poised to do to prescription drug companies, pharmacy chains, and drug distributors what they did to tobacco companies and asbestos manufacturers — wring from them a multibillion dollar settlement, with a sizeable chunk going to the lawyers themselves.